ST2 for the Management of Heart Failure

Conditions: Heart Failure, Diastolic Heart Failure, Systolic Heart Failure Stage C

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 123

Sponsor: University Hospital, Montpellier

Location: University Regional Hospital Arnaud de Villeneuve Montpellier Languedoc-Roussillon

Summary

Heart failure (HF) is a severe disease, burdened with a poor prognosis (30% mortality at 2 years, 30% of rehospitalization within 1 month). It is also a major cause of health burden representing between 1.5 and 2 billions euros per year in France. Approximately 75% of these costs are due to hospitalization. Besides physical examination and echocardiography, biology may help refine the diagnosis, but also could provide powerful prognostic parameters. This study aims to assess the value of ST2 in the management of patients admitted for HF to reduce readmission at one month.

Eligibility Criteria

Inclusion Criteria: * Heart failure hospitalization Exclusion Criteria: * Other study * Pregnancy, feeding * Refusal * Not possible to perform information

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02963272). StuddyBuddy aggregates publicly available trial information.

ST2 for the Management of Heart Failure - STADE-HF

Summary

Eligibility Criteria